NurExone Biologic Inc, a global pharmaceutical company developing platform for biologically─guided exosome─based therapies to deliver...
Vous n'êtes pas connecté
NurExone Biologic (TSXV:NRX) is developing a pioneering exosome-based product for first indications from spinal cord injury.
NurExone Biologic Inc, a global pharmaceutical company developing platform for biologically─guided exosome─based therapies to deliver...
MONDAY, Aug. 19, 2024 -- A fish might hold clues to healing spinal cord injuries in humans, researchers report.The damaged nerve cells of zebrafish...
A Bermudian-based insurance company that operates entirely in bitcoin has become the first to receive a Class IILT licence from the Bermuda Monetary...
SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late...
IKEA has announced the next phase in its drone technology: an upgraded AI-powered system capable of operating alongside co-workers around the clock....
Ovarian cancer is one of the most common malignancies in women worldwide. Unlike breast cancer, ovarian cancer lacks early diagnostic markers and does...
Nigerian oil and gas company UTM Offshore aims to make FID on its pioneering FLNG facility in Nigeria in 2024, with production targeted for 2026. The...
Apple 2024 Product Lineup is Shaping Up TECH DIGEST- Apple is gearing up for a significant product release cycle in 2024, with the highly anticipated...
Dementia Australia has welcomed the recent approval of Lecanemab by the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA). This...
StarTimes, a leading media company in Africa, is thrilled to announce that it has secured the all-media broadcasting rights of the Bundesliga for the...